{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T07:04:54Z","timestamp":1783667094164,"version":"3.55.0"},"reference-count":43,"publisher":"Walter de Gruyter GmbH","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_dx-2025-0023_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Scandinavian evaluation of laboratory equipment for point of care testing (SKUP) provides objective and supplier-independent information about analytical quality and user-friendliness of point-of-care (POC) measuring systems. The evaluation reports are freely available online and are valuable tools when selecting fit-for-purpose POC equipment. In this study, we present an overview of the performance of four POC measuring systems for monitoring prothrombin time international normalized ratio (INR) assessed against updated analytical performance specifications (APSs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_dx-2025-0023_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Primary healthcare centres (PHCCs) in Sweden and Norway did the practical work under real-life conditions. In each evaluation, 2\u20134 PHCCs participated with at least 40 patients on Warfarin treatment per site. Capillary samples were measured on the POC INR systems (qLabs Q3 Plus PT-INR Owren, Xprecia Stride, microINR or ProTime InRhythm), with venous samples analysed at hospital laboratories for comparison (STA-R Evolution or Sysmex CS5100). In the current study, APSs from SKUP, ISO 17593:2022, and CLSI POCT14-Ed2 were used. User-friendliness was assessed by addressing operational facilities, user-manual, time factors, and quality control.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_dx-2025-0023_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Only microINR coagulometer met the APS for accuracy, while qLabs Q3 Plus PT-INR Owren and ProTime InRhythm met the repeatability criteria. Xprecia Stride scored highest on user-friendliness, whereas the other systems faced challenges with sample application and unclear error messages on the devices.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_dx-2025-0023_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study highlights the potential for improvements in POC INR measuring systems and underscores the importance of performing objective evaluations under real-life conditions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/dx-2025-0023","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T15:58:19Z","timestamp":1747929499000},"page":"432-440","source":"Crossref","is-referenced-by-count":2,"title":["Analytical performance and user-friendliness of four point-of-care measuring systems for monitoring prothrombin time international normalized ratio in the hands of the intended users"],"prefix":"10.1515","volume":"12","author":[{"given":"D\u00e5r Kristian","family":"Kur","sequence":"first","affiliation":[{"name":"Danish Institute for External Quality Assurance for Laboratories in the Health Sector (DEKS), Rigshospitalet Glostrup , Glostrup , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabet","family":"Eriksson Boija","sequence":"additional","affiliation":[{"name":"Equalis AB , Uppsala , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Morken","sequence":"additional","affiliation":[{"name":"The Norwegian Organization for Quality Improvement of Laboratory Examinations (Noklus), Haraldsplass Deaconess Hospital , Bergen , Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sverre","family":"Sandberg","sequence":"additional","affiliation":[{"name":"The Norwegian Organization for Quality Improvement of Laboratory Examinations (Noklus), Haraldsplass Deaconess Hospital , Bergen , Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0159-7706","authenticated-orcid":false,"given":"Anne","family":"Stavelin","sequence":"additional","affiliation":[{"name":"The Norwegian Organization for Quality Improvement of Laboratory Examinations (Noklus), Haraldsplass Deaconess Hospital , Bergen , Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"key":"2025121206492416007_j_dx-2025-0023_ref_001","doi-asserted-by":"crossref","unstructured":"Schein, JR, White, CM, Nelson, WW, Kluger, J, Mearns, ES, Coleman, CI. Vitamin K antagonist use: evidence of the difficulty of achieving and maintaining target INR range and subsequent consequences. Thromb J 2016;14:1\u201310. https:\/\/doi.org\/10.1186\/s12959-016-0088-y.","DOI":"10.1186\/s12959-016-0088-y"},{"key":"2025121206492416007_j_dx-2025-0023_ref_002","doi-asserted-by":"crossref","unstructured":"Mackman, N. Triggers, targets and treatments for thrombosis. Nature 2008;451:914\u20138. https:\/\/doi.org\/10.1038\/nature06797.","DOI":"10.1038\/nature06797"},{"key":"2025121206492416007_j_dx-2025-0023_ref_003","doi-asserted-by":"crossref","unstructured":"Murray, ET, Fitzmaurice, DA, McCahon, D. Point of care testing for INR monitoring: where are we now? Br J Haematol 2004;127:373\u20138. https:\/\/doi.org\/10.1111\/j.1365-2141.2004.05154.x.","DOI":"10.1111\/j.1365-2141.2004.05154.x"},{"key":"2025121206492416007_j_dx-2025-0023_ref_004","doi-asserted-by":"crossref","unstructured":"Kristoffersen, A-H, Thue, G, Ajzner, E, Claes, N, Horvath, AR, Leonetti, R, et al.. Interpretation and management of INR results: a case\u00a0history\u00a0based survey in 13 countries. Thromb Res 2012;130:309\u201315. https:\/\/doi.org\/10.1016\/j.thromres.2012.02.014.","DOI":"10.1016\/j.thromres.2012.02.014"},{"key":"2025121206492416007_j_dx-2025-0023_ref_005","doi-asserted-by":"crossref","unstructured":"Shermock, KM, Connor, JT, Lavallee, DC, Streiff, MB. Clinical decision-making as the basis for assessing agreement between measures of\u00a0the\u00a0International Normalized Ratio. J\u00a0Thromb Haemost 2009;7:87\u201393. https:\/\/doi.org\/10.1111\/j.1538-7836.2008.03225.x.","DOI":"10.1111\/j.1538-7836.2008.03225.x"},{"key":"2025121206492416007_j_dx-2025-0023_ref_006","doi-asserted-by":"crossref","unstructured":"Moore, GW, Henley, A, Cotton, SS, Tugnait, S, Rangarajan, S. Clinically significant differences between point-of-care analysers and a standard analyser for monitoring the International Normalized Ratio in oral anticoagulant therapy: a multi-instrument evaluation in a hospital outpatient setting. Blood Coagul Fibrinolysis 2007;18:287\u201392. https:\/\/doi.org\/10.1097\/mbc.0b013e328040c105.","DOI":"10.1097\/MBC.0b013e328040c105"},{"key":"2025121206492416007_j_dx-2025-0023_ref_007","doi-asserted-by":"crossref","unstructured":"Ansell, J, Hirsh, J, Hylek, E, Jacobson, A, Crowther, M, Palareti, G. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2008;133:160S\u201398S. https:\/\/doi.org\/10.1378\/chest.08-0670.","DOI":"10.1378\/chest.08-0670"},{"key":"2025121206492416007_j_dx-2025-0023_ref_008","doi-asserted-by":"crossref","unstructured":"Stavelin, A, R\u00f8nneseth, E, Gidske, G, Solsvik, AE, Sandberg, S. Using three external quality assurance schemes to achieve equivalent international normalized ratio results in primary and secondary healthcare. Clin Chem Lab Med 2023;61:419\u201326. https:\/\/doi.org\/10.1515\/cclm-2022-1080.","DOI":"10.1515\/cclm-2022-1080"},{"key":"2025121206492416007_j_dx-2025-0023_ref_009","doi-asserted-by":"crossref","unstructured":"Sephel, GC, Laposata, M. Transiently increased variation between a point-of-care and laboratory INR method after a long period of correlation: a case study demonstrating the need for ongoing correlation of POC with the central laboratory. Am J Clin Pathol 2013;140:475\u201386. https:\/\/doi.org\/10.1309\/ajcpe2z0evfetjqt.","DOI":"10.1309\/AJCPE2Z0EVFETJQT"},{"key":"2025121206492416007_j_dx-2025-0023_ref_010","doi-asserted-by":"crossref","unstructured":"Kjeldsen, J, Lassen, JF, Petersen, PH, Brandslund, I. Biological variation of International Normalized Ratio for prothrombin times, and consequences in monitoring oral anticoagulant therapy: computer simulation of serial measurements with goal-setting for analytical quality. Clin Chem 1997;43:2175\u201382. https:\/\/doi.org\/10.1093\/clinchem\/43.11.2175.","DOI":"10.1093\/clinchem\/43.11.2175"},{"key":"2025121206492416007_j_dx-2025-0023_ref_011","doi-asserted-by":"crossref","unstructured":"Merli, GJ, Tzanis, G. Warfarin: what are the clinical implications of an out-of-range-therapeutic international normalized ratio? J\u00a0Thromb Thrombolysis 2009;27:293\u20139. https:\/\/doi.org\/10.1007\/s11239-008-0219-9.","DOI":"10.1007\/s11239-008-0219-9"},{"key":"2025121206492416007_j_dx-2025-0023_ref_012","unstructured":"Danish Institute for External Quality Assurance for Laboratories in Health Care (DEKS). Available from: https:\/\/deks.dk."},{"key":"2025121206492416007_j_dx-2025-0023_ref_013","unstructured":"External quality assessment in laboratory medicine in Sweden (Equalis). Available from: https:\/\/equalis.se."},{"key":"2025121206492416007_j_dx-2025-0023_ref_014","unstructured":"Norwegian quality improvement of primary care laboratories (Noklus). https:\/\/noklus.no [Accessed]."},{"key":"2025121206492416007_j_dx-2025-0023_ref_015","unstructured":"ISO 17593:2022. Clinical laboratory testing and in vitro medical devices\u00a0\u2014 Requirements for in vitro monitoring systems for self-testing of oral anticoagulant therapy, 1st ed. Geneva: International Organization for Standardization."},{"key":"2025121206492416007_j_dx-2025-0023_ref_016","unstructured":"CLSI. Point-of-Care coagulation testing and anticoagulation monitoring. In: CLSI guideline POCT14, 2nd ed. USA: Clinical and Laboratory Standards Institute; 2020."},{"key":"2025121206492416007_j_dx-2025-0023_ref_017","unstructured":"SKUP. Report from the evaluation SKUP\/2021\/123. qLabs Q-3 Plus PT (INR) Owren (dry) (Micropoint Bioscience, Inc.), a system for measurement of PT(INR). Available from: www.skup.org."},{"key":"2025121206492416007_j_dx-2025-0023_ref_018","unstructured":"SKUP. Report from the evaluation SKUP\/2016\/110. Xprecia Stride Coagulation system, a system for measurement of PT(INR). Available from: www.skup.org."},{"key":"2025121206492416007_j_dx-2025-0023_ref_019","unstructured":"SKUP. Report from the evaluation SKUP\/2015\/109. microINR portable coagulometer, a system for measurement of PT(INR). Available from:www.skup.org."},{"key":"2025121206492416007_j_dx-2025-0023_ref_020","unstructured":"SKUP. Report from the evaluation SKUP\/2014\/104. The ProTime InRhythm System, a system for measurement of PT(INR). Available from: www.skup.org."},{"key":"2025121206492416007_j_dx-2025-0023_ref_021","doi-asserted-by":"crossref","unstructured":"Adcock, FDM, Lippi, G, Favaloro, EJ. Quality standards for sample processing, transportation, and storage in hemostasis testing. Semin Thromb Hemost 2012;38:576\u201385. https:\/\/doi.org\/10.1055\/s-0032-1319768.","DOI":"10.1055\/s-0032-1319768"},{"key":"2025121206492416007_j_dx-2025-0023_ref_022","doi-asserted-by":"crossref","unstructured":"Baglin, T, Luddington, R. Reliability of delayed INR determination: implications for decentralized anticoagulant care with off-site blood sampling. Br J Haematol 1997;96:431\u20134. https:\/\/doi.org\/10.1046\/j.1365-2141.1997.d01-2079.x.","DOI":"10.1046\/j.1365-2141.1997.d01-2079.x"},{"key":"2025121206492416007_j_dx-2025-0023_ref_023","doi-asserted-by":"crossref","unstructured":"Lindahl, TL, Egberg, N, Hillarp, A, Odegaard, OR, Edlund, B, Svensson, J, et al.. INR calibration of Owren-type prothrombin time based on the relationship between PT% and INR utilizing normal plasma samples. Thromb Haemost 2004;91:1223\u201331. https:\/\/doi.org\/10.1160\/th03-07-0456.","DOI":"10.1160\/TH03-07-0456"},{"key":"2025121206492416007_j_dx-2025-0023_ref_024","unstructured":"Carnicelli, A. Anticoagulation for valvular heart disease. USA: Am Coll Cardiol; 2015."},{"key":"2025121206492416007_j_dx-2025-0023_ref_025","doi-asserted-by":"crossref","unstructured":"Gallus, AS, Baker, RI, Chong, BH, Ockelford, PA, Street, AM. Consensus guidelines for warfarin therapy: recommendations from the australasian society of thrombosis and Haemostasis. Med J Aust 2000;172:600\u20135. https:\/\/doi.org\/10.5694\/j.1326-5377.2000.tb124127.x.","DOI":"10.5694\/j.1326-5377.2000.tb124127.x"},{"key":"2025121206492416007_j_dx-2025-0023_ref_026","unstructured":"Kvalitetssikring og kvalitetskrav til laboratoriemedicinske aktiviteter i almen praksis. Udarbejdet af Regionernes L\u00f8nnings- og Takstn\u00e6vn (RTLN og Praktiserende L\u00e6gers Organisation (PLO). https:\/\/wwwlaegerdk\/media\/igjgkjew\/kvalitetssikring_og_kvalitetskrav_til_laboratoriemedicinske_aktiviteter_i_almen_praksis_2010pdf2010."},{"key":"2025121206492416007_j_dx-2025-0023_ref_027","unstructured":"Trydal, T, Bolann, B, Brosstad, F, Sandberg, S, Sandset, PM, Stavelin, A, et al.. [Analysis of prothrombin time in primary health care]. Tidsskr Nor Laegeforen 2005;125:2048\u20139."},{"key":"2025121206492416007_j_dx-2025-0023_ref_028","doi-asserted-by":"crossref","unstructured":"Burnett, RW. Accurate estimation of standard deviations for quantitative methods used in clinical-chemistry. Clin Chem 1975;21:1935\u20138. https:\/\/doi.org\/10.1093\/clinchem\/21.13.1935.","DOI":"10.1093\/clinchem\/21.13.1935"},{"key":"2025121206492416007_j_dx-2025-0023_ref_029","unstructured":"CLSI. EP07 Supplement: supplemental tables for interference testing in clinical chemistry. CLSI guideline EP07.1st ed.; 2018. Published https:\/\/clsi.org\/standards\/products\/method-evaluation\/documents\/ep07-supplement\/ [Accessed]."},{"key":"2025121206492416007_j_dx-2025-0023_ref_030","unstructured":"Chantarangkul, V, Tripodi, A, Van den Besselaar, A. Guidelines for thromboplastins and plasma used to control oral anticoagulant therapy with vitamin K antagonists. World Health Organ Tech Rep Ser 2013;979:273\u2013305."},{"key":"2025121206492416007_j_dx-2025-0023_ref_031","unstructured":"CLSI. Procedures for validation of INR and Local calibration of PT\/INR systems; Approved guideline. In: CLSI document H54-A 2005. USA: Clinical and Laboratory Standards Institute; 2005."},{"key":"2025121206492416007_j_dx-2025-0023_ref_032","doi-asserted-by":"crossref","unstructured":"van den Besselaar, AM, van Rijn, CJ, Abdoel, CF, Chantarangkul, V, Scalambrino, E, Kitchen, S, et al.. Paving the way for establishing a reference measurement system for standardization of plasma prothrombin time: harmonizing the manual tilt tube method. J\u00a0Thromb Haemost 2020;18:1986\u201394. https:\/\/doi.org\/10.1111\/jth.14873.","DOI":"10.1111\/jth.14873"},{"key":"2025121206492416007_j_dx-2025-0023_ref_033","doi-asserted-by":"crossref","unstructured":"Stavelin, A, Sandberg, S. Analytical performance specifications and quality assurance of point-of-care testing in primary healthcare. Crit Rev Clin Lab Sci 2024;61:164\u201377. https:\/\/doi.org\/10.1080\/10408363.2023.2262029.","DOI":"10.1080\/10408363.2023.2262029"},{"key":"2025121206492416007_j_dx-2025-0023_ref_034","doi-asserted-by":"crossref","unstructured":"van den Besselaar, AM, Stavelin, A, Kitchen, S, Bryant, M, Tripodi, A, Scalambrino, E, et al.. Defining a metrologically traceable and sustainable calibration hierarchy of international normalized ratio for monitoring of vitamin K antagonist treatment in accordance with International Organization for Standardization (ISO) 17511: 2020 standard: communication from the International Federation of Clinical Chemistry and Laboratory Medicine\u2013SSC\/ISTH working group on prothrombin time\/international normalized ratio standardization. J\u00a0Thromb Haemostasis 2024;22:1236\u201348. https:\/\/doi.org\/10.1016\/j.jtha.2023.12.013.","DOI":"10.1016\/j.jtha.2023.12.013"},{"key":"2025121206492416007_j_dx-2025-0023_ref_035","doi-asserted-by":"crossref","unstructured":"Wool, GD. Benefits and pitfalls of point-of-care coagulation testing for anticoagulation management: an ACLPS critical review. Am J Clin Pathol 2019;151:1\u201317. https:\/\/doi.org\/10.1093\/ajcp\/aqy087.","DOI":"10.1093\/ajcp\/aqy087"},{"key":"2025121206492416007_j_dx-2025-0023_ref_036","doi-asserted-by":"crossref","unstructured":"Dillinger, JG, Moussi, TS, Berge, N, Sollier, CBD, Henry, P, Drouet, L. Accuracy of point of care coagulometers compared to reference laboratory measurements in patients on oral anticoagulation therapy. Thromb Res 2016;140:66\u201372. https:\/\/doi.org\/10.1016\/j.thromres.2016.02.006.","DOI":"10.1016\/j.thromres.2016.02.006"},{"key":"2025121206492416007_j_dx-2025-0023_ref_037","doi-asserted-by":"crossref","unstructured":"Van Den Besselaar, A, Van Der Meer, F, Abdoel, C, Witteveen, E. Analytical accuracy and precision of two novel Point-of-Care systems for INR determination. Thromb Res 2015;135:526\u201331. https:\/\/doi.org\/10.1016\/j.thromres.2014.12.022.","DOI":"10.1016\/j.thromres.2014.12.022"},{"key":"2025121206492416007_j_dx-2025-0023_ref_038","doi-asserted-by":"crossref","unstructured":"McCahon, D, Roalfe, A, Fitzmaurice, DA. An evaluation of a coagulation system (Xprecia Stride) for utilisation in anticoagulation management. J\u00a0Clin Pathol 2018;71:20\u20136. https:\/\/doi.org\/10.1136\/jclinpath-2017-204456.","DOI":"10.1136\/jclinpath-2017-204456"},{"key":"2025121206492416007_j_dx-2025-0023_ref_039","doi-asserted-by":"crossref","unstructured":"Braham, S, Novembrino, C, Moia, M, Torresani, E, Tripodi, A. Evaluation\u00a0of\u00a0a new PT-INR monitoring system in patients with\u00a0the\u00a0antiphospholipid syndrome. Int J Lit Humanit 2016;38:497\u2013504. https:\/\/doi.org\/10.1111\/ijlh.12523.","DOI":"10.1111\/ijlh.12523"},{"key":"2025121206492416007_j_dx-2025-0023_ref_040","doi-asserted-by":"crossref","unstructured":"Ganapati, A, Mathew, J, Yadav, B, Kabeerdoss, J, Gowri, M, Dave, RG, et al.. Comparison of point-of-care PT-INR by hand-held device with conventional PT-INR testing in anti-phospholipid antibody syndrome patients on oral anticoagulation. Indian J Hematol Blood Transfus 2023;39:450\u20135. https:\/\/doi.org\/10.1007\/s12288-022-01611-4.","DOI":"10.1007\/s12288-022-01611-4"},{"key":"2025121206492416007_j_dx-2025-0023_ref_041","doi-asserted-by":"crossref","unstructured":"Sanfilippo, S, Buisson, L, Rouabehi, H, Dujaric, M-E, Donnet, T, de Raucourt, E, et al.. The qLabs\u00ae FIB system, a novel point-of-care technology for a rapid and accurate quantification of functional fibrinogen concentration from a single drop of citrated whole blood. Thromb Res 2023;226:159\u201364. https:\/\/doi.org\/10.1016\/j.thromres.2023.03.018.","DOI":"10.1016\/j.thromres.2023.03.018"},{"key":"2025121206492416007_j_dx-2025-0023_ref_042","doi-asserted-by":"crossref","unstructured":"Piacenza, F, Galeazzi, R, Cardelli, M, Moroni, F, Provinciali, M, Pierpaoli, E, et al.. Precision and accuracy of the new XPrecia Stride mobile coagulometer. Thromb Res 2017;156:51\u20133. https:\/\/doi.org\/10.1016\/j.thromres.2017.05.032.","DOI":"10.1016\/j.thromres.2017.05.032"},{"key":"2025121206492416007_j_dx-2025-0023_ref_043","doi-asserted-by":"crossref","unstructured":"Refaai, MA, Shah, V, Fernando, R. Performance of the microINR point-of-care system: a multicenter clinical trial. Thromb Haemost 2020;120:687\u201391. https:\/\/doi.org\/10.1055\/s-0040-1708034.","DOI":"10.1055\/s-0040-1708034"}],"container-title":["Diagnosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/dx-2025-0023\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/dx-2025-0023\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T07:11:57Z","timestamp":1765523517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/dx-2025-0023\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":43,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,5,23]]},"published-print":{"date-parts":[[2025,8,7]]}},"alternative-id":["10.1515\/dx-2025-0023"],"URL":"https:\/\/doi.org\/10.1515\/dx-2025-0023","relation":{},"ISSN":["2194-802X"],"issn-type":[{"value":"2194-802X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,23]]}}}